Afterwards, SLC31A1-knockdown tumors progressively shrank in vivo (Fig. 10A), showing that SLC31A1, a tumor-promoting factor, significantly downregulated cell proliferation after its knockdown in Her2 + enriched BC cells. This evidence concerns the gene ERBB2 and breast cancer.